-
Single-arm trial of neoadjuvant ipilimumab plus nivolumab with chemoradiotherapy in patients with resectable and borderline resectable lung cancer: The INCREASE study
Bahce, I., Dickhoff, C., Schneiders, F. L., Veltman, J., Heineman, D. J., Hashemi, S. M. S., Vrijmoet, A., Houda, I., Ulas, E. B., Bakker, J., van de Ven, P., Bouwhuis, N., Meijboom, L. J., Oprea-Lager, D. E., van Maldegem, F., Fransen, M. F., de Gruijl, T. D., Radonic, T. & Senan, S., 30 Sept 2024, In: Journal for Immunotherapy of Cancer. 12, 9, e009799.Research output: Contribution to journal › Article › Academic › peer-review
-
Unresectable Stage III NSCLC Can Be Reevaluated for Resectability After Initial Treatment
Dickhoff, C., Heineman, D. J., Bahce, I. & Senan, S., 1 Sept 2023, In: Journal of Thoracic Oncology. 18, 9, p. 1124-1128 5 p.Research output: Contribution to journal › Editorial › Academic › peer-review
-
Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
Dickhoff, C., Unal, S., Heineman, D. J., Winkelman, J. A., Braun, J., Bahce, I., van Dorp, M., Senan, S. & Dahele, M., 1 Aug 2023, In: Lung Cancer. 182, 107294.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
-
Optimal treatment and pain management for pneumothrorax
Dickhoff, C., 1 Jun 2026Research output: PhD thesis › Research external, graduation external
-
Loss of Myonuclei and Transcriptional Activity During Diaphragm Atrophy in Critically Ill Patients
Claassen, W. J., van den Berg, M., Shi, Z. H., Baelde, R. J., Bogaards, S., Bonis, L., Hakkeling, H., Bamyani, A., Schaaf, G. J., Beishuizen, A., Dickhoff, C., Boon, R. A., Heunks, L., Kirby, T. J. & Ottenheijm, C. A. C., Feb 2026, In: Journal of cachexia, sarcopenia and muscle. 17, 1, p. e70228 e70228.Research output: Contribution to journal › Article › Academic › peer-review
-
Immune-modulating effects on tumor-draining lymph nodes of neoadjuvant chemoradiotherapy combined with dual immunotherapy in patients with T3-4N0-2 NSCLC
Ulas, E. B., Koomen, S. J. I., Vrijmoet, A., Houda, I., Korkmaz, H. I., Dickhoff, C., Bahce, I., Senan, S., de Gruijl, T. D., Fransen, M. F., Radonic, T., van Maldegem, F. & Schneiders, F. L., 28 Nov 2025, In: Journal for Immunotherapy of Cancer. 13, 11, e013237.Research output: Contribution to journal › Article › Academic › peer-review
- All publications